GenixPharmaceucticals Corporation (GENX) — Strategic Asset Allocation Index
GenixPharmaceucticals Corporation (GENX) has a Strategic Asset Allocation Index of 0.1% as of October 2022. Strategic assets (PP&E of CA$3.73K plus long-term investments of CA$-) total CA$3.73K, measured against net assets of CA$3.20 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
GenixPharmaceucticals Corporation Strategic Asset Allocation Index (2015–2022)
This chart shows how GenixPharmaceucticals Corporation's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2022. As of October 2022, the index stands at 0.1%, representing strategic assets of CA$3.73K against net assets of CA$3.20 Million CAD. Explore GENX cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for GenixPharmaceucticals Corporation (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for GenixPharmaceucticals Corporation from 2015 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of GenixPharmaceucticals Corporation.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | CA$3.73K | CA$3.73K | CA$- | CA$3.20 Million | ▼ -0.7 pp |
| 2021 | 0.8% | CA$32.43K | CA$32.43K | CA$- | CA$4.01 Million | ▲ +0.6 pp |
| 2018 | 0.2% | CA$253.00 | CA$253.00 | CA$- | CA$122.57K | ▼ -87.0 pp |
| 2017 | 87.2% | CA$105.46K | CA$105.46K | CA$- | CA$120.97K | ▲ +47.5 pp |
| 2016 | 39.7% | CA$152.46K | CA$152.46K | CA$- | CA$384.43K | ▲ +1.4 pp |
| 2015 | 38.2% | CA$193.74K | CA$193.74K | CA$- | CA$506.89K | — |